Affiliation:
1. Department of Pharmacy, The 967th Hospital of Joint Logistic Support Force of PLA, Dalian, China
2. College of Pharmacy, Harbin University of Commerce, Harbin, China
3. College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
Abstract
Cancer, which has been cursed for human beings for long time is considered as one of the
leading causes of morbidity and mortality across the world. In spite of different types of treatments
available, chemotherapy is still deemed as a favored treatment for the cancer. Unfortunately, many currently
accessible anticancer agents have developed multidrug resistance along with fatal adverse effects.
Therefore, intensive efforts have been made to seek for new active drugs with improved anticancer efficacy
and reduced adverse effects. In recent years, the emergence of heterocyclic ring-containing anticancer
agents has gained a great deal of attention among medicinal chemists. 1,3- oxazole is a versatile
heterocyclic compound, and its derivatives possess broad-spectrum pharmacological properties, including
anticancer activity against both drug-susceptible, drug-resistant and even multidrug-resistant cancer
cell lines through multiple mechanisms. Thus, the 1,3-oxazole moiety is a useful template for the development
of novel anticancer agents. This review will provide a comprehensive overview of the recent
advances on 1,3-oxazole derivatives with potential therapeutic applications as anticancer agents, focus
on the chemical structures, anticancer activity, and mechanisms of action.
Funder
University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Reference153 articles.
1. Vineis P.; Wild C.P.; Global cancer patterns: causes and prevention. Lancet 2014,383(9916),549-557
2. Rojas C.; Casablanca Y.; Chemotherapy, biologic, and immunotherapy breakthroughs in cancer care. Obstet Gynecol Clin North Am 2019,46(1),137-154
3. International Agency for Research on Cancer. Latest global cancer
data: Cancer burden rises to 18.1 million new cases and 9.6 million
cancer deaths in 2018, Available from: 2018
4. International Agency for Research on Cancer. Cancer Tomorrow. Available from
5. Dickens E.; Ahmed S.; Principles of cancer treatment by chemotherapy. Surgery 2018,36(3),134-148
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献